If You Suffer from Migraine, Can You Honestly Say that You are Satisfied with Your Current Treatment?

The Emerge Study is evaluating a new investigational treatment for migraine.

Your acute migraine doesn’t have to keep you in the dark. Consider the EMERGE Study today.

You may be able to participate in the Emerge Study if:

The investigational medication is taken as powder that is administered into your nose.

You will receive all study-related care at no cost.  Health insurance is not needed.

About Migraine

Migraine is a common, but incapacitating, neurological disease that affects approximately 39 million people in the United States alone.

Migraine is the

3rd

most prevalent illness in the world

Migraine typically involves a severe throbbing recurring pain, usually on one side of the head.

Migraine is most common between the ages of 25 and 55.

About

0 %

of migraine sufferers have a family history of migraine.

Attacks are often accompanied by one of more of the following: nausea, vomiting, extreme sensitivity to sound, light, touch and smell, and tingling or numbness of the extremities of face.

Attacks usually last between 4 and 72 hours.

There is still so much research that needs to be done so better treatments can come to the market. This is where the EMERGE Study comes in.

Source: migraineresearchfoundation.org

The EMERGE Study is evaluating a new investigational treatment for migraine.